Articles citing this paper

Dr Vivek Shetty received his Ph.D in mass spectrometry from the Indian Institute of Chemical Technology, India. He was also the recipient of the prestigious Humboldt Fellowship. Dr Shetty has published 42 research articles on mass spectrometry-based genomics and proteomics. As a Director at Immunotope, Inc., he led the analytical team which discovered novel glycoprotein biomarkers and MHC peptide antigens in cancer and infectious diseases. He is currently working as a scientist at Progenics Pharmaceuticals, Inc., in New York. Dr Shetty's research interests are in glycoprotein biomarker and MHC peptide antigen discovery, cysteine proteomics, and the characterization of antibodies and antibody drug conjugates.

Dr Ramila Philip is the scientific founder of Immunotope, Inc., and is currently the President and Chief Scientific Officer. She earned her Ph.D. in immunology in India and did post-doctoral training at the Institute of Immunology, Basel, Switzerland, and was a junior faculty member at the Cancer Research Institute, UCSF. She has held a number of senior level positions in pharmaceutical and biotechnology companies, and currently holds an adjunct professorship at Drexel University and a professorship at the Institute for Hepatitis and Virus Research. Dr Philip's research focus is in immunotherapy and clinical studies. She has over 75 peer-reviewed publications to her name.